The Impacts of Nirmatrelvir –Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic
ConclusionNirmatrelvir –ritonavir was effective in reducing myocardial injury as well as long-term adverse cardiovascular outcomes among hospitalized patients with COVID-19 amid the omicron wave of the pandemic.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Arrhythmia | Cardiology | Cardiovascular | COVID-19 | Heart | Heart Attack | Heart Failure | Norvir | Pandemics | Stroke | Study | Ventricular Arrhythmia